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chromatographyAbstract Liquid phase extraction with back extraction (LPE-BE) combined with high perfor-
mance liquid chromatography-diode array detection (HPLC-DAD) was applied for the extraction
and determination of erythromycin A, B and C in fermentation broths. According to this proce-
dure, the fermentation broth with the adjustment pH at a ﬁxed value of 10 was ﬁrst mixed with
organic solvent (Vbroth/Vorg = 1.0). After shaking, the mixture was separated into two phases by
microfuging at 13,000 rpm for 15 min. Then back extraction was performed into the acidic aqueous
phase with pH 5.0 (Vorg/Vaq = 1.0). After centrifugation at 3000, the two phases were separated
and 50 lL of the acidic aqueous phase was injected into the HPLC. The effects of different
variables such as the nature of extraction solvent and the pH of samples and buffer were investi-
gated. At the most appropriate conditions, dynamic linear ranges of 0.5–8, 0.1–0.9 and 0.1–
0.9 mg mL1 and limits of detection of 0.03, 0.003 and 0.002 mg mL1 were obtained for erythro-
mycin A, B and C, respectively. Relative standard deviations (RSDs) of the proposed method were
less than 9.5%. The mean recoveries were 99.5%. The proposed method is simple and sensitive with
highly clean-up effect and it can be used for monitoring the progress of erythromycin fermentation.
ª 2010 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Erythromycin is a macrolide antibiotic, produced by fermenta-
tion of Saccharopolyspora (Ribeiro and Ribeiro, 2005). Pro-
duction and biosynthesis of erythromycin are extensively
under investigation. (Bushell et al., 1997; Heydarian et al.,
1996). The fermentation produces not only erythromycin A
(EA) but also small quantities of related substances such as
N-dimethyl EA and erythromycin B, C, D, E and F (Fig. 1).
Determination of erythromycins in fermentation broth 293Determination of erythromycin and its related substances in
fermentation broth is performed by high performance liquid
chromatography after a sample pretreatment step such as
liquid–liquid extraction (LLE) (Tsuji and Goetz, 1978;
Chepkwony et al., 2001; Trilli et al., 1987) and solid phase
extraction (SPE) (Heydarian et al., 1998). By using LLE as a
pretreatment procedure, other materials in fermentation sam-
ples such as proteins, nutrient, oil and impurities, along with
erythromycin, might be extracted. Therefore, LLE is not a
sensitive method for complex matrixes. SPE is a time-consum-
ing method in which a solvent evaporation step is required in
order to preconcentrate the analytes before ﬁnal analyses
(Ebrahimzadeh et al., 2007). Liquid phase extraction with back
extraction (LPE-BE), a three phase extraction technique, is
suitable for puriﬁcation of ionizable compounds. It also over-
comes many drawbacks of conventional LLE or SPE methods
as it is simple, inexpensive, fast and sensitive. In this study, the
sample is adjusted to pH, where the analytes are in their neu-
tral forms. Then by mixing sample with organic solvent, the
neutral molecules are transferred into the organic phase.
During back extraction, the neutral molecules, present in the
organic phase, are ionized with the acceptor solution. By
shaking, ionizable compounds are extracted into the organic
solvent and then back extracted into the acceptor solution,
which can be directly analysed. The simplicity of operation,
short time, high sensitivity and recovery are the advantages
of LPE-BE.Figure 1 Chemical structuThe aim of the present study was to investigate the feasibil-
ity of LPE-BE to extract and determine erythromycin A and its
related substances in fermentation broth. Various parameters
including type of organic solvent, pH of sample and buffer
solution on the extraction efﬁciency were investigated and
optimized.
2. Experimental
2.1. Reagents
Anuh pharma LTD (Mumbai, India) reference standard of
erythromycin base containing 93.5% erythromycin A and
USP reference standard (RS) of erythromycin B and C were
used throughout the study. Potassium dihydrogen phosphate
and dipotassium hydrogen phosphate were obtained from
Fluka (Buchs, Switzerland). HPLC grade acetonitrile was pur-
chased from Caledon (Georgetown, Ont., Canada). Ammonia
solution 25%, dibuthyl ether, n-butylacetate, and ethyl acetate
were purchased fromMerck (Darmstadt, Germany). Ultrapure
water was prepared using a Milli-Q system from Millipore
(Bedford, MA, USA). Fermentation broth samples were
obtained from Shafa-e-Sari Company (Tehran, Iran).
2.2. Preparation of standard solutions and real samples
Stock standard solutions containing 10 mg mL1 of erythro-
mycin A, 1 mg mL1 of erythromycin B, 1 mg mL1 of eryth-res of EA, EB and EC.
Figure 3 Effect of fermentation broth’s pH on the extraction of
analytes. 500 lL broth containing 5, 0.5 and 0.5 mg mL1 of EA,
EB and EC, respectively, was extracted using n-butylacetate, then
back extracted into a buffer KH PO (25 mM) adjusted to pH 6.
294 F. Kamarei et al.romycin C were prepared in acetonitrile and stored in a fridge
at 4 C. Stability of standard solution (3 days) was tested at
+4 C temperature and the result showed that concentration
changes during storage were less than 0.5%. The working
solutions were prepared daily by diluting the standard
solutions prior to use. Free erythromycin fermentation broth
samples and the industrial fermentation broth containing
about 5–8 mg mL1 erythromycin were used.
2.3. Apparatus
Injection of the samples into high performance liquid chroma-
tography (HPLC) was carried out using a 50-lL Hamilton
(Bonaduz, Switzerland). Separation and quantiﬁcation of
erythromycin and its related substances were carried out using
Shimadzu LC-10AD VP HPLC system from Shimadzu Com-
pany (Kyoto, Japan) equipped with a diode array detector.
LC-solution was used for the acquisition and processing of
the data. Chromatographic separations were carried out using
a Shim-Pack CLC-C18 analytical column (250 · 4.6 mm I.D.,
5 lm) from Shimadzu (Kyoto, Japan). A mixture of
10 mmol L1 of potassium dihydrogen phosphate buffer and
acetonitrile (55:45) adjusted to pH 7.0 and a ﬂow rate of
1.0 mL min1 was used as a mobile phase in isocratic elution
mode. The injection volume was 50 lL for all the samples
and the detection was performed at the wavelength of
205 nm. The column temperature was controlled at 50 C by
oven column. Three blank samples of standard solution were
analysed after injection of high concentration of erythromyc-
ins. The results showed no memory effect on HPLC column.
Eppendorf microfuge model 5415C (Golden valley, MN,
USA) and Hettich centrifuge model EBA 20 (Oxford, Eng-
land) were employed for phase separation.
2.4. LPE-BE procedure
500 lL of fermentation broth sample with pH 10 containing
erythromycin was placed in a 1.5 mL micro tube. 500 lL of
n-butylacetate (as extraction solvent) was added into the sam-
ple. The mixture was gently shaken for 5 min. The mixture was
then microfuged at 13000 rpm for 15 min. Then the organicFigure 2 Scheme of LPE-BE tphase containing the analytes was mixed with 500 lL acceptor
solution with pH 5. After centrifuging at 3000 rpm for 5 min,
the two phases were separated and 50 lL of the acceptor solu-
tion was injected into HPLC. The entire scheme of the proce-
dure is shown in Fig. 2.
3. Results and discussion
3.1. Study of the experimental parameters
The important aims of the three phase LPE are to separate and
clean-up the analytes from the complex matrixes and to pro-
vide efﬁcient pretreatment prior to HPLC determination. It in-
volves the extraction of ionizable compounds from the
aqueous sample at suitable pH into the organic solvent, fol-
lowed by back-extraction into the receiving aqueous phase
by adjusting the pH to the desired value. In this study, LPE-
BE combined with HPLC-DAD was developed for extraction
and determination of erythromycin A, B and C in fermenta-
tion broths. In order to achieve maximum extraction efﬁ-
ciency, various parameters affecting the extraction efﬁciency
were optimized. The optimization was carried out by free
erythromycin fermentation broth samples with addition of 5,2 4
echnique for erythromycins.
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respectively.
3.1.1. Selection of extraction solvent
Extraction efﬁciency is directly inﬂuenced by the nature of the
organic solvent. Thus, the organic solvent requires characteris-
tics such as immiscibility with sample solution, low volatility
and higher afﬁnity to the drug (He and Kang, 2006). In fer-
mentation broth, there exist some components in culture med-
ium such as proteins, polysaccharides, and nutrient which
would sediment during microfugation. Therefore, it is better
to use a solvent with lower density than water. In this case
after microfugation the organic solvent ﬂoats on the sample.
Considering these facts, dibutyl ether, n-butylacetate, and ethyl
acetate were tested for their suitability. Among these solvents,
n-butylacetate offered the highest efﬁciency. Therefore, it was
used for subsequent studies.
3.1.2. Effect of fermentation broth’s pH
Fermentation broth’s pH has a very important role in the
extraction efﬁciency. Since, EA is a weak basic compound
(pKa 8.25) (Galichet, 1986), the drug was deionized under basic
conditions in sample and its solubility in the sample was re-
duced. Thus, by mixing sample with organic solvent, erythro-
mycin and its related substances were extracted into the
organic phase. The initial pH of the fermentation broth is in
the range of 4.6–6.6. Therefore, extraction of the analytes
was performed in the range of pH = 8–12, using concentrated
ammonia solution (25% w/w). As shown in Fig. 3, the peak
area rises by increasing the pH value. Therefore, the pH of
the fermentation broth was adjusted to 10 in further studies.Figure 4 Effect of acceptor solution’s pH on the extraction of
analytes. 500 lL broth containing 5, 0.5 and 0.5 mg mL1 of EA,
EB and EC, respectively, at pH 10 was extracted using
n-butylacetate, then back extracted into the acceptor solution.
Table 1 Figures of merit of the proposed method.
Analyte LOD (mg mL1) r2 Regression
Erythromycin A 0.03 0.9994 Y= 1636.
Erythromycin B 0.003 0.9986 Y= 2460.
Erythromycin C 0.002 0.9994 Y= 1807
a Concentration in mg mL1.3.1.3. Effect of acceptor solution’s pH
For the back-extraction process, the neutral molecules, present
in the organic phase, should be extracted into the acceptor
solution by protonation of the analytes. In this case, the accep-
tor solution’s pH should be acidic in order to ionize the ana-
lytes. Therefore, the effect of acceptor solution’s pH on the
transport efﬁciency was investigated in the range of 5–7.5 using
KH2PO4 (25 mM) buffer. Since, erythromycin is prone to deg-
radation at lower pH, therefore, pH <5.0 was not tested. As
shown in Fig. 4 the maximum peak area was obtained at pH
5.0. at higher values, the extraction efﬁciency decreased due
to the incomplete protonation of the analytes. Thus, the pH
of buffer solution was adjusted to 5.0 in further studies.
3.1.4. Effect of ionic strength
The effect of ionic strength on extraction efﬁciency was exam-
ined by adding sodium chloride to fermentation broth samples
at the percentage levels of 0–10% (W/V). The results showed
that no considerable change in the extraction efﬁciency was
observed. So, all the subsequent experiments were performed
in the absence of salt.equation DLR (mg mL1) Extraction recovery (%)
1 Ca + 1155 0.5–8 99.5
3 C + 5921 0.1–0.9 99.2
C + 197.61 0.1–0.9 99.4
Figure 5 Chromatogram of fermentation broth sample after
LPE-BE under optimum conditions. Peak: (1) EC; (2) EA; (3) EB.
Table 2 Determination of erythromycins in fermentation broth of Shafa-e-Sari Pharmaceutical Company (Iran).
Sample Analyte
Erythromycin A Erythromycin B Erythromycin C
Cadded
(mg mL1)
Cfound
(mg mL1)
RSD
(%)
E
(%)
Cadded
(mg mL1)
Cfound
(mg mL1)
RSD
(%)
E
(%)
Cadded
(mg mL1)
Cfound
(mg mL1)
RSD
(%)
E
(%)
1 – 4.32 7.5 – – 0.72 8.1 – – 0.29 8.9 –
4.0 7.92 7.6 10.0 1.0 1.61 8.4 11.0 0.5 0.74 9.1 10.0
2 – 4.80 7.8 – – 0.78 8.9 – – 0.33 8.8 –
4.0 8.35 8.1 11.2 1.0 1.68 8.1 10.0 0.5 0.88 8.7 10.0
3 – 4.60 8.2 – – 0.75 7.9 – – 0.34 9.5 –
4.0 8.15 7.9 11.3 1.0 1.84 8.4 9.0 0.5 0.89 9.3 10.0
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Under optimum conditions, limits of detections (LODs),
regression equations, correlation coefﬁcients (r2), dynamic lin-
ear ranges (DLRs) and extraction recoveries (ERs) were ob-
tained (Table 1). The LODs were calculated as the analytes
concentration equal to three times of the standard deviation
of the blank signal divided by the slope of the calibration
curve. The extraction recovery (R) was expressed as the per-
centage of total analyte amount, which was transferred to
the acceptor phase at the end of the extraction.
The analytes showed good linearity with correlation of
determination in the range of 0.9986–0.9994. The applicability
of the extraction method to real samples was examined by
extraction and determination of EA, EB and EC in the indus-
trial fermentation broths of Shafa-e-Sari Company (Tehran,
Iran).
A chromatogram of the fermentation broth after LPE-BE
at the optimum condition is shown in Fig. 5. Table 2 shows
that the results of four replicate analytes of each sample ob-
tained by the proposed method and the amount of added ana-
lytes are in satisfactory agreement with each other. Percent
errors for determination of the analytes in different fermenta-
tion broth samples were located in the range of 9.0–11.3. On
the other hand, the proposed method revealed suitable repro-
ducibility with RSD values in the range of 7.5–9.5%.
4. Conclusions
The proposed liquid phase extraction with back extraction is a
very fast and simple method for extraction and determination
of milligram per milliliter concentration of erythromycin from
fermentation broth. There is no need of dedicated and expen-sive apparatus. Simplicity and cost-effectiveness of the
proposed method make it quite attractive when compared to
LLE or SPE. The most important advantage of the proposed
method is the ability of separation and puriﬁcation of the ana-
lytes from complex matrixes. This technique is rapid, econom-
ical, applicable and suitable for the routine quality control
analysis of erythromycin in fermentation broth.Acknowledgement
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